AI assistant
Sending…
HARROW, INC. — Director's Dealing 2020
May 23, 2020
31774_dirs_2020-05-22_8a7938bf-aff3-4914-a1fe-2353df452a2f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-05-14
Reporting Person: Opaleye Management Inc. (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.001 par value | 2480500 | Indirect |
| Common Stock, $0.001 par value | 118600 | Indirect |
Footnotes
F1: Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. ("Opaleye") may be deemed to beneficially own the securities owned directly by the Fund.
F2: Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8